-
Bone Biologics (BBLG) Regains Nasdaq Compliance
-
Bone Biologics (BBLG) Files $35M Mixed Shelf
-
Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split
-
Bone Biologics (BBLG) Appoints Phillip T. Meikle to its Board
-
Bone Biologics (BBLG) Announces Exercise of Warrants for $2.1M Gross Proceeds

